Add Yahoo as a preferred source to see more of our stories on Google. Novo Nordisk won't add Alzheimer's disease to the list of conditions its blockbuster diabetes and weight-loss drugs, Ozempic and ...
Novo Nordisk won't add Alzheimer's disease to the list of conditions its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, can treat, despite high hopes and two years of study. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results